Aehr Test Systems Surges 144.2% Amid Record Order Growth
Aehr Test Systems' shares surged by 144.2% in April 2026, crossing above the 5-day SMA, reflecting strong market confidence in the company's growth prospects.
The significant increase in stock price is attributed to Aehr securing its largest order ever, a $41 million follow-on order from a hyperscale customer, with shipments expected to begin in fiscal year 2027. Additionally, the company's backlog of unfilled orders reached $38.7 million, up from $18.2 million a year ago, indicating robust demand and strong support for future revenues.
Despite reporting net losses and sales below expectations in Q3 2026, the optimism surrounding Aehr's order growth in the semiconductor sector suggests a positive outlook for the company's future development.
Trade with 70% Backtested Accuracy
Analyst Views on AEHR
About AEHR
About the author

- Stock Surge: Aehr Test Systems' shares skyrocketed by 144.2% in April 2026, indicating a doubling of stock price within a month, reflecting strong market confidence in the company's future growth prospects.
- Backlog Growth: By the end of Q3 2026, Aehr's backlog of unfilled orders reached $38.7 million, significantly up from $18.2 million a year ago, providing robust support for future revenues and indicating strong market demand.
- Historic Order: On April 16, Aehr secured its largest order ever, a $41 million follow-on order from an existing hyperscale customer, with revenue-generating shipments expected to commence in fiscal year 2027, further driving revenue growth.
- Market Trend Impact: Despite reporting net losses and sales below expectations in Q3 2026, investors remain optimistic about Aehr's strong order growth in the semiconductor sector, reflecting confidence in the company's future development.
- Partnership Expansion: Bloom Energy has expanded its partnership with Oracle, which plans to procure up to 2.8 GW of solid-oxide fuel cell systems, with 1.2 GW already contracted for deployment at Oracle's U.S. AI and cloud data centers, significantly enhancing Oracle's energy efficiency in the AI sector.
- Strong Financial Performance: Bloom Energy reported a revenue of $751.1 million for the March quarter, a 130% increase year-over-year, easily surpassing market expectations of $540.02 million, indicating robust demand and growth potential in the fuel cell market.
- Upgraded Outlook: The company raised its 2026 revenue outlook to between $3.4 billion and $3.8 billion, implying approximately 80% growth at the midpoint, reflecting optimistic market sentiment, with multiple brokerages raising their price targets accordingly.
- Positive Market Sentiment: Retail sentiment for Bloom Energy remains in the 'extremely bullish' territory, accompanied by extremely high message volumes, indicating strong investor confidence in the company's future performance, further driving its stock price upward.
- Transaction Overview: Halter Ferguson Financial Inc. reduced its position in Aehr Test Systems by 627,498 shares in Q1 2026, with an estimated value of approximately $20.07 million, indicating a cautious outlook on the company's future performance.
- Position Change: By quarter-end, Halter Ferguson held only 14,631 shares of Aehr Test, valued at $542,522, which now accounts for just 0.12% of its 13F reportable assets, reflecting the stock's marginalization in its investment portfolio.
- Stock Performance: As of April 27, 2026, Aehr Test's stock price was $88.48, up 917.0% year-over-year, significantly outperforming the S&P 500 by 880.21 percentage points, showcasing strong market expectations for its future growth.
- Market Outlook Analysis: Despite the substantial rise in Aehr Test's stock price, its net revenue for the fiscal third quarter was only $10.3 million, down from $18.3 million the previous year, indicating that while market enthusiasm is high, actual sales have not kept pace, leading to a price-to-sales ratio nearing 60, suggesting it may be a good time to sell rather than buy.
- Transaction Overview: Rhea J. Posedel, a board member of Aehr Test Systems, sold 17,719 shares of common stock for approximately $1.77 million, indicating ongoing adjustments in her ownership structure within the company.
- Ownership Changes: Post-transaction, Posedel holds 45,261 shares directly and 396,375 shares indirectly, with direct holdings now representing 0.14% of the company's outstanding shares, reflecting a gradual decline in her ownership stake.
- Price Assessment: The weighted average sale price of around $99.83 per share was approximately 2.5% above the closing price of $97.36 on April 22, 2026, indicating that the transaction was executed within the market price range, suggesting a degree of market confidence.
- Investor Outlook: Despite a year-over-year decline in sales to $10.3 million in Q3, strong demand from AI customers has led investors to remain optimistic about future order growth, which is expected to drive sales increases down the line.
- Stock Option Exercise: Fariba Danesh, a director at Aehr Test Systems, exercised 8,000 stock options and immediately sold the shares on April 16, 2026, with a transaction value of approximately $661,000, indicating a liquidity-driven decision rather than a bullish outlook on the stock.
- Ownership Changes: Following this transaction, Danesh retains 13,143 shares valued at around $1.09 million, representing a 0.04% ownership stake in the company, highlighting a decline in her direct holdings which may limit future trading capacity.
- Market Performance: The shares were sold at a weighted average price of about $82.63 each, while Aehr's stock has surged 890.8% year-over-year as of April 16, 2026, suggesting she capitalized on significant gains by selling at a peak.
- Order Incentive: On the same day Danesh sold her shares, Aehr announced a $41 million order from an AI hyperscale customer, marking the largest production order in the company's history, which could drive future sales growth despite recent declines in revenue.
- Share Sale Details: On April 16, 2026, Fariba Danesh, a director at Aehr Test Systems, sold 8,000 shares for approximately $661,000, representing 37.8% of her direct holdings, reducing her ownership from 21,143 to 13,143 shares, indicating ongoing portfolio management.
- Price Impact: The sale coincided with Aehr's stock reaching a 52-week high of $91.43, driven by the announcement of a $41 million order from an AI hyperscale customer, marking the largest production order in the company's history, which could enhance future sales growth.
- Market Outlook: Despite a decline in third-quarter sales to $10.3 million from $18.3 million year-over-year, the strong demand in the AI sector supports Aehr's future performance, highlighting its critical role in the semiconductor testing equipment market.
- Investor Caution: While Danesh's sale is not necessarily a negative signal, Aehr's high price-to-sales ratio exceeding 55 suggests elevated stock prices, prompting caution for potential investors, especially as it was not included in the Motley Fool's recommended stocks list.











